The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors.
Abstract Details
Novel Hepatitic C Virus (HCV) Diagnosis and Treatment Delivery Systems: Facilitating HCV Elimination by Thinking Outside the Clinic
J Infect Dis. 2020 Nov 27;222(Supplement_9):S758-S772. doi: 10.1093/infdis/jiaa366.
Sahar Bajis1, Tanya L Applegate1, Jason Grebely1, Gail V Matthews1, Gregory J Dore1
Author information
1The Kirby Institute, UNSW Sydney, Sydney, New South Wales, Australia.
Abstract
The World Health Organization has set a goal to eliminate hepatitis C virus (HCV) infection as public health threat by 2030. Although the advent of highly effective and tolerable direct-acting antiviral therapy has paved the way for HCV elimination, most people with HCV infection remain undiagnosed and untreated globally, with striking disparities between high-income and low- to middle-income countries. Novel decentralized and cost-effective "test-and-treat" strategies are critically needed to identify the millions of people unaware of their status and link them to treatment.